Last edition
News about "lung cancer "
AstraZeneca Enters into Global License Agreement with with Dizal Pharmaceutical for Zegfrovy
AstraZeneca has entered a global licensing agreement with Dizal Pharmaceutical for Zegfrovy, expanding its EGFR-targeted lung cancer portfolio.
Lung Cancer | 15/07/2026 | By News Bureau
The silicon photonics based imaging platform, Leadoptik’s LIA system, delivers real-time, high-resolution tissue insight at the point of care, addressing a critical gap in lung cancer diagnosis.
Lung Cancer | 16/01/2026 | By News Bureau | 588
MediLink, Roche Sign Global Licensing Deal for YL201 ADC Therapy
Agreement includes USD 570 million upfront and milestones to advance B7H3-targeting solid tumor cancer treatment worldwide.
Lung Cancer | 09/01/2026 | By News Bureau | 507
Bayer and Kumquat Biosciences have begun a Phase-I trial of their KRAS G12D inhibitor targeting KRAS-mutated tumors, further bolstering Bayer’s precision oncology pipeline across pancreatic, colorectal, and lung cancers.
Lung Cancer | 11/10/2025 | By Dineshwori | 1036
Galvanize Therapeutics Begins Clinical Study of Aliya Pulsed Electric Field Ablation
Galvanize Therapeutics has announced the enrollment of the first patient in the PROPEL Registry, a multicenter observational study designed to evaluate the clinical application, safety, and outcomes of the Aliya Pulsed Electric Field (PEF) ablation system for soft tissue lesions.
Lung Cancer | 18/08/2025 | By Dineshwori | 349
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy